Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NaHS inhibits cell proliferation by enhancing oxidative stress and apoptosis in HCT116 cells.

Molecular biology reports·2026
Same author

Evaluation of Cutaneous Leishmaniasis Cases in the Southeastern Border of Turkey in Recent Years.

Iranian journal of public health·2026
Same author

Impact of Multidrug-Resistant Uropathogens on Mortality in Elderly Patients with Urinary Tract Infections: A Multicenter Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Organizational happiness and its association with organizational commitment: A mixed-methods study among private school teachers in Türkiye.

PloS one·2026
Same author

Comparison of treatment plans for patients with high-grade brain tumors using two different treatment planning systems in radiotherapy.

Journal of X-ray science and technology·2026
Same author

Climate-driven restructuring of phytoplankton productivity and community composition in the south-eastern black sea: Insights from seasonal CO<sub>2</sub>-Temperature manipulation experiments.

Marine environmental research·2026

Related Experiment Video

Updated: May 18, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Brivudin induced delirium: a case report.

Ibak Gonen1, Hakan Turan, Davud Ozdemir

  • 1Department of Infectious Diseases, School of Medicine, University of Duzce, Duzce, Turkey. dribak77@hotmail.com

Journal of Chemotherapy (Florence, Italy)
|October 9, 2012
PubMed
Summary

Brivudin, an antiviral for herpes zoster, may cause delirium. This rare side effect resolved after stopping the medication, highlighting the importance of clinician awareness for patient recovery.

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Experiment Videos

Last Updated: May 18, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Pharmacology
  • Neurology
  • Infectious Diseases

Background:

  • Brivudin is an oral antiviral medication prescribed for herpes zoster (shingles) infections.
  • Commonly reported side effects include nausea and headache.
  • The safety profile of brivudin is generally well-established for its intended use.

Observation:

  • This case report details a patient experiencing delirium during brivudin treatment for herpes zoster.
  • The onset of delirium occurred after four days of medication use.
  • The patient's symptoms significantly improved upon discontinuation of brivudin.

Findings:

  • Delirium is identified as a potential, previously unreported adverse effect of brivudin.
  • Cessation of brivudin treatment led to the complete remission of the delirium.
  • This suggests a direct link between brivudin and the observed neurological side effect.

Implications:

  • Clinicians prescribing brivudin should be vigilant for potential neurological side effects like delirium.
  • Awareness of this adverse event can guide prompt diagnosis and management.
  • Early recognition and drug cessation are likely to result in full clinical recovery for affected patients.